As shown in Figure 4, mil40-15 showed higher cytotoxicity and maximum inhibition rate compared with mil40 in all HER2-positive tumor cell lines, and the activity of mil40-15 in antigen-negative cells can be significantly reduced by 279–1276-fold compared to the antigen-positive cells (Table 2). The gene discussed is ERBB2; the disease is neoplasm.